
Starting July 1, 2025, Florida law allows licensed physicians to offer stem cell therapies for orthopedic, pain, and wound care—if you meet compliance standards. Position your clinic at the forefront of the booming biologics market projected to reach $300B+ by 2030.
Licensed MDs and DOs can now legally offer certain unapproved stem cell therapies
Treatments limited to orthopedic conditions, pain management, and wound care
Law goes into effect July 1, 2025 - time to prepare your practice now
Strict standards must be met to avoid penalties and maximize benefits
SB 1768 creates a clear pathway for Florida physicians to offer stem cell therapies, but with strict requirements. Violations can result in felony charges, making proper compliance essential for your practice.
Regenerative Research Group provides turnkey solutions to ensure your clinic meets every standard—from sourcing to documentation to patient consent.
Our comprehensive compliance program covers every aspect of SB 1768, protecting your practice while maximizing this new revenue opportunity.
Therapies must be administered by a licensed MD or DO within their scope of practice
Materials must come from accredited facilities with full documentation and chain of custody
Detailed consent forms and specific FDA disclaimers required by law
Comprehensive records must be maintained for each treatment cycle
Current market value (2024)
Expected US market by 2030
Americans with applicable conditions
CAGR across key sectors
For the first time, Florida clinics can legally offer these high-demand, cash-based services. This allows you to add a profitable new modality, increase revenue per visit, and differentiate your practice with cutting-edge therapies patients are actively seeking.
After stem cell therapy, I avoided surgery and returned to training faster than expected. It's been a game-changer for my competitive career.
Kris, Competitive Heavyweight Athlete
Kris represents the real-world impact our regenerative therapies deliver. His experience demonstrates the powerful recovery advantages now available to your patients.
Higher patient satisfaction and clinical outcomes
Materials preserved within hours of collection
Proprietary methods ensure high post-thaw cellular activity
Complete tracking from donation to delivery
No third-party tissue banks means better verification
Our proprietary processing methods and direct sourcing network ensure you receive materials with maximum therapeutic potential, meeting all compliance requirements while delivering superior patient outcomes.
Pre-built, legally-reviewed informed consent documents that satisfy all SB 1768 requirements
Required 8.5"x11" notices with 40-point font disclaimers ready for display
Compliant language for all advertising and promotional materials
Documentation designed to protect against regulatory liability
Navigating the regulatory landscape between federal prohibitions and Florida's new law requires precision. Our plug-and-play compliance tools eliminate guesswork and minimize legal risk for your practice.
Direct relationships with verified providers, not anonymous tissue banks
Multi-generational health history and lifestyle verification
Thorough genetic screening eliminates hereditary concerns
Transparent, fully documented donation processes
Complete paperwork trail for regulatory protection
Unlike competitors who rely on third-party tissue banks, our direct sourcing model gives you unparalleled insight into material origins, superior quality control, and comprehensive documentation that exceeds compliance requirements.
Compliance audit and readiness evaluation
Workflow templates and documentation setup
Front desk to provider education programs
Complete marketing funnel and sales support
We don't just deliver products—we provide complete success systems. From initial compliance preparation through ongoing marketing support, our team walks with you every step of the way to ensure a successful and profitable regenerative medicine program.
One of our partner clinic generated over $72,000 in additional revenue within the first 30 days of implementing our regenerative medicine programs, all while maintaining 100% compliance with standards identical to SB 1768.
Competitive heavyweight athlete Kris avoided surgery and returned to training faster after stem cell therapy. Many other patients have been supported their recovery aat the cellular level.
Our comprehensive training programs ensure your entire team understands the regulatory requirements and clinical protocols necessary for successful, compliant implementation of regenerative therapies under Florida's new legislation.
We've already helped clinics nationwide implement regenerative programs that meet or exceed Florida's upcoming standards. Our proven systems deliver both clinical excellence and financial results.
During your complimentary consultation, we'll assess your clinic's current setup, discuss your goals for implementing regenerative therapies, and provide a customized roadmap for compliance with SB 1768. You'll receive actionable insights regardless of whether you partner with us.
SB 1768 takes effect July 1, 2025. However, preparation should begin now to ensure your clinic is fully compliant on day one. Our pre-launch program helps you build systems, train staff, and develop marketing strategies so you're ready to capture this opportunity immediately.
Unlike competitors who simply provide products, we offer a complete launch solution including compliance documentation, direct-sourced materials with superior viability, staff training, and ongoing marketing support. Our unique direct sourcing network eliminates third-party tissue banks for better quality control and documentation.
Book your free readiness consultation
Receive your custom compliance plan
Set up procedures with our support
Begin offering services July 1, 2025
Florida Clinics: SB 1768 Opens the Door to Regenerative Medicine